NewBay Pharma
PrivateLast Round
Series B
Apr 16, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NewBay Pharma operates in Healthcare & Life Sciences and is based in Ningbo. Its latest recorded funding round was a Series B round in April 2026.
NewBay Pharma is a biotechnology company that develops oncology drugs and small molecule therapies for patients with advanced solid tumors and gastrointestinal stromal tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NewBay Pharma Comparables
Compare NewBay Pharma with similar companies based on industry and business-model similarity.
No comparables are published for NewBay Pharma. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
NewBay Pharma Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
NewBay Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bayland Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Raised Series B round with Bayland Capital participating.
For institutional investors. Book with your work email.
NewBay Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NewBay Pharma's valuation, stock price, and market status.
Is NewBay Pharma a public or private company?
NewBay Pharma is a private company.
What is the current stock price of NewBay Pharma?
NewBay Pharma is a private company, so its shares have no public market price. Caplight tracks NewBay Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NewBay Pharma worth (valuation)?
Valuation information for NewBay Pharma is not publicly available.
Can I buy NewBay Pharma stock?
NewBay Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NewBay Pharma's last funding round?
NewBay Pharma's most recent funding round was Series B on April 16, 2026.
Who are the main investors in NewBay Pharma?
Key investors in NewBay Pharma include Bayland Capital.
Will NewBay Pharma IPO soon?
No public IPO plans have been announced for NewBay Pharma.
How can I track NewBay Pharma secondary market activity?
Caplight tracks bids, offers, and trades in NewBay Pharma's shares on secondary markets.